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Hemorrhage is the major cause of early death in severely injured patients. In civilian emergency medical
services, the majority of life-threatening bleedings are found in noncompressible body regions (e.g.
abdomen and pelvis). Resuscitative endovascular balloon occlusion of the aorta (REBOA) has therefore
been discussed in recent years as a possible lifesaving procedure and numerous studies, meta-analyses and
guidelines have been published. In this review, the data situation of REBOA in the management of
bleeding trauma patients is discussed and practical implementation is depicted.
Recent findings
The typical indication for REBOA is a traumatic life-threatening hemorrhage below the diaphragm in
patients unresponsive or only transiently responsive to the usual conservative therapeutic measures. REBOA
appears to be a safe and effective procedure to reduce blood loss and stabilize the patient’s hemodynamic
status. However, surgical hemostasis has to be achieved within 30–60 min after occlusion of the aorta.
Data on clear advantages of REBOA over resuscitative thoracostomy are inconclusive.
Summary
REBOA could play an important role in the management of the severely bleeding patient in the future.
Together with transfusion and therapy of coagulation disorders, REBOA may be an additional tool in the
anesthetist’s hands for trauma management in interprofessional care concepts.
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Hemorrhage is responsible for 30–40% of fatalities
among severely injured patients. In particular,
hypotensive trauma patients with serious noncom-
pressible bleeding have a high mortality rate of up
to 85%. Although bleeding in the extremities can
generally be managed by manual compression, the
vast majority of cases of life-threatening bleeding
encountered by civilian rescue services in Europe are
found in noncompressible body regions such as the
pelvis and the abdomen. For these regions, there are
unfortunately no effective measures for early hem-
orrhage control, with the exception of the pelvic
sling/binder. As a result, the mortality of patients
with such injuries is high [1,2].
Aortic occlusion is a potentially valuable tool for
early resuscitation of patients nearing extremis or in
arrest from severe hemorrhage. Resuscitative endo-
vascular balloon occlusion of the aorta (REBOA) can
quickly and significantly reduce blood loss in case ofrs Kluwer Health, Inc. All rights rese
Kluwer Health, Inc. Unamajor bleeding from abdominal and pelvic injuries,
and increase afterload for the perfusion of the heart
and brain. It has therefore been discussed in recent
years as a possible lifesaving procedure and has been
mentioned in numerous published studies, meta-
analyses and guidelines [3
&&
,4
&
,5–14,15
&
,16–18,19
&
].
This procedure has been applied for many years
in vascular surgical clinics to temporarily controlrved. www.co-anesthesiology.com
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KEY POINTS
 Noncompressible torso hemorrhage continues to be a
problem in the management of severely injured
patients, and often results in death.
 For life-threatening hemorrhage in the subphrenic
region, REBOA appears to be a safe and effective
procedure for rapidly reducing blood loss and for
stabilizing the hemodynamic status.
 REBOA can provide approximately 30–60 min of time
until definitive surgical hemostasis in the abdomen or pelvis.
 To date, it is unclear whether resuscitative thoracotomy
with open compression of the aorta or REBOA should
be the preferred method.
 Before REBOA and be implemented, clear
interdisciplinary instructions must be developed, and
training courses for the entire team must take place.
Trauma and transfusion
Copbleeding in patients with ruptured aortic aneurysms.
REBOA has also been successfully used to reduce blood
loss during elective pelvis and liver surgery, following
rupture of a splenic artery aneurysm, for postpartum
hemorrhage in clinical as well as out-of-hospital set-
tings, and even in a combat environment [20–28].
The objective of this overview is to show the
potential of REBOA in the acute medical care of
bleeding trauma patients, to explain its technical
application – particularly under emergency medical
conditions – to discuss the advantages and disad-
vantages of REBOA and to compare them to other
invasive procedures (e.g. resuscitative thoracotomy)
and to draw practical conclusions for the establish-
ment of REBOA in the field of emergency medicine.MATERIALS AND METHODS
This narrative review summarizes current literature
about REBOA in patients with life-threatening (trau-
matic) torso hemorrhage. As far as possible, it was
written in accordance with the PRISMA guidelines
[29]. InAugust 2018,we conducteda literature review
in the PubMed database for the period 2016–2018
using the keywords ‘REBOA’, ‘balloon occlusion’ and
‘trauma’. The authors supplemented their findings
with a manual search of publications as well as their
own clinical experience and opinions [14].ENDOVASCULAR BALLOON OCCLUSION
OF THE AORTA
Preparation
All required material (introducer sheath, guide
wires, occlusion catheters, surgical set for vessel2 www.co-anesthesiology.com
yright © 2019 Wolters Kluwer Health, Inc. Unauthexposure and fixation of the catheter) must be
checked for compatibility and packed in a set in
advance. Figure 1 [14] and Table 1 [14] provide an
overview of currently available products and their
characteristics. As REBOA is not performed fre-
quently, an interdisciplinary and interprofessional
checklist should be prepared.
Because of low incidence rates even in major
trauma centers (i.e. 1–2 cases per year per level I
trauma center in the United Kingdom [30] or
Germany [31]), suitable training programmes for
all members of the trauma team must be organized,
with special emphasis on local equipment and
standards [32–34] (c.f. Figure 2a–h) [34].Arterial cannulation
The major rate-limiting step when using REBOA is
the safe cannulation of the common femoral artery
(CFA) in a patient in shock [19
&
], especially in car-
diac arrest [35]. The site of access for REBOA is the
CFA [3
&&
]. Neither the superficial femoral artery nor
the iliac artery should be used. Whether to remove a
previously applied pelvis binder/sling is a decision of
the trauma leader. We feel that removal should be
avoided, and recommend pelvis slings that allow
medical personnel to cut a triangular opening in the
groin region with clothing scissors so that the artery
is accessible [5].
Cannulation is generally carried out via an ultra-
sound-guided percutaneous puncture, or alterna-
tively via an open surgical cut-down technique
[4
&
,5,13,19
&
]. The use of ultrasound is essential for
safe puncture of the CFA.
If the primary survey reveals injuries to the
abdomen or pelvis that might be indications for
REBOA, clinicians should consider using the CFA as
the primary site for invasive blood pressure mea-
surement as opposed to the radial artery. In
this way, REBOA can be established easily if indi-
cated in the further course without an additional
puncture. Operators must ensure the compatibility
of the sheath system guide wires with the catheters
for invasive blood pressure measurement in
advance.Position of the balloon
For positioning of the balloon, three different sec-
tions of the aorta are distinguished (Fig. 3) [36,14]:(1)oriZone I: branch of the left subclavian artery to
branch of the celiac trunk,(2) Zone II: between celiac trunk and renal arteries
(nonocclusion zone),(3) Zone III: infrarenal abdominal aorta.Volume 31  Number 00  Month 2019
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FIGURE 1. (a) ER-REBOA catheter. Modified figure courtesy of Prytime Medical, Boerne, Texas, USA. Adapted from Knapp
et al. [14]. (b) RELIANT Stent Graft Balloon Catheter. Modified figure courtesy of Medtronic, Santa Rosa, California, USA.
Adapted from Knapp et al. [14].
Resuscitative endovascular balloon occlusion of the aorta Kulla et al.
C
The balloon catheter is inflated in zone I for
control of severe intra-abdominal or retroperitoneal
hemorrhage, or for patients with traumatic arrest.0952-7907 Copyright  2019 Wolters Kluwer Health, Inc. All rights rese
opyright © 2019 Wolters Kluwer Health, Inc. UnaFor patients with severe pelvic, junctional or proxi-
mal lower extremity hemorrhage, zone III occlusion
is called for [19
&
]. Positioning the balloon in zone II
should be avoided because of the possible occlusionrved. www.co-anesthesiology.com 3
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Table 1. Description of various endovascular catheters for resuscitative endovascular balloon occlusion of the aorta
Product Manufacturer
Minimal
sheath size
Balloon
diameter Length Characteristics
ER-REBOA Prytime Medical Devices
(Boerne, Texas, USA)
7 Fr 32 mm 72 cm Connector for invasive blood pressure
monitoring
Soft, specially shaped tip (c.f.
Figure 1A)
No guide wire needed
Visible length and radiographic marker
Arterial monitoring port distal balloon
Rescue Balloon
Occlusion
Catheter
Tokai Medical Products
(Kasugai, Aichi, Japan)
7 Fr 40 mm 100 cm Visible length and radiographic marker
Soft tip
Set with a special guide wire in order to
keep the balloon in position (e.g.
during partial REBOA)
Market leader in Japan
Coda COOK Medical
(Bloomington, Indiana,
USA)
14 Fr 46 mm 120 cm Standard tip
Coda-LP COOK Medical
(Bloomington, Indiana,
USA)
12 Fr 32 mm 100 cm Standard tip
RELIANT Stent Graft
Balloon Catheter
Medtronic (Santa Rosa,
California, USA)
12 Fr 10–46mm 100 cm Standard tip (c.f. Figure 1B)
Guide wire needed (0.038‘‘ or smaller)
REBOA and further indications
Fogarty Occlusion
Catheter
Edwards Lifesciences
(Irvine, California, USA)
8 Fr 45 mm 80 cm Different configurations available
Q50 PLUS Stent
Graft Balloon
Catheter
Qx Médical (Montreal,
Quebec, Canada)
12 Fr 10–50mm 65 cm and
100cm
models
Initially designed for EVAR / TEVAR and
so on.
Guide wire needed (0.038‘‘ or 0.035‘‘)
ResQ Occlusion
Balloon Catheter
Qx Médical (Montreal,
Quebec, Canada)
11 Fr 10–38mm 67 cm Available only in the United States
EU, European Union; EVAR, endovascular aortic repair; Fr, French; TEVAR, thoracic endovascular aortic repair.
The specifications came from the manufacturers (modified from Knapp et al. [14]).
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Copof the celiac trunk or the superior mesenteric artery,
leading to mesenteric ischemia [36].
The approximate insertion depth for position-
ing the balloon in the desired zone should be esti-
mated beforehand on the basis of anatomical
landmarks [37–40]:(1)4
yrigZone I occlusion: the direct distance between
the puncture site and the middle of the patient’s
sternum (proximal end of the balloon, c. f.
Figure 1a–b)(2) Zone III occlusion: the direct distance between
the puncture site and the navel. Alternatively,
the balloon can be allowed to migrate in a distal
direction until occlusion is achieved above the
aortic bifurcation. The latter is the preferred
method in the prehospital setting.During resuscitation, the correct position of the
balloon must be reassessed regularly. For zone I place-
ments, a transesophageal echocardiogram can be used
as with the placement of intra-aortic balloon pumps.www.co-anesthesiology.com
ht © 2019 Wolters Kluwer Health, Inc. UnauthAlternatively, a radiograph of the chest or abdomen
will normally allow clinicians to check the approxi-
mate position of the balloon. For a zone I REBOA, the
balloon should be positioned in the thoracic spine
from Th 4 to Th 11, and for a zone III occlusion below
L 2. Under good ultrasound conditions, abdominal
sonography may suffice for assessing positions in zone
III. Of course, the position can also be checked with
whole-body computed tomography.Occlusion phase and immediate surgical
hemostasis
The volume required to inflate the balloon depends
on the manufacturer and the balloon’s position
(Table 1). In zone I, the aorta usually has a diameter
of 1.8–2.5 cm. Consequently, 8 ml of insufflation
volume is required for an ER-REBOA catheter and
9–10 ml for a RELIANT catheter. The volumes
needed for zone III occlusion (physiological aortic
diameter: 1.3–1.8 cm) are 5 and 4–6 ml, respec-
tively. The goal is a loss of pulsatile blood flowVolume 31  Number 00  Month 2019
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FIGURE 2. (a–h): REBOA education (a), training (b–g) and clinical impression (h). (a) Education of REBOA with special
emphasis of local equipment. (b) Training with a model. (c) Human cadaver training at the University of Heidelberg,
Germany, during the INTECH Advanced Course: Ultrasound of femoral vessels [34]. (d) Human cadaver training at the
University of Heidelberg, Germany, during the INTECH Advanced Course: open preparation of femoral artery [34]. (e)
Human cadaver training at the University of Heidelberg, Germany, during the INTECH Advanced Course: insertion of sheet
[34]. (f) Human cadaver training at the University of Heidelberg, Germany during the INTECH Advanced Course: Placement
of REBOA catheter [34]. (g) Perfused human cadaver training during a training course at Armed Forces Hospital, Berlin,
Germany (courtesy of Lt Col. Dr. Hauer). (h) Clinical impression of a patient with REBOA in situ after futile resuscitation
attempts in the ER.
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(measured invasively at the sheath or in the contra-
lateral femoral artery) distal to the balloon. Over-
inflating the balloon must be avoided.
The balloon position must be well stabilized in
order to avoid distal dislocation as a result of blood
flow. This is particularly the case if a guide wire-free
occlusion catheter such as the ER-REBOA is used.
Reasons for dislocation are catheter kinking and the
lack of fixation options with various products. Thus,
a long sheath is recommended for a zone I occlusion0952-7907 Copyright  2019 Wolters Kluwer Health, Inc. All rights rese
opyright © 2019 Wolters Kluwer Health, Inc. Unato improve catheter stabilization and assisting staff
should hold the catheter in place as long as it is not
securely fixed [36].
If a REBOA catheter is used which does not allow
blood pressure to be measured distal of the occlu-
sion, pressure must be measured invasively at an
upper extremity. This should ideally be done on the
left arm in order to rule out overly proximal posi-
tioning of the balloon and the risk of cerebral ische-
mia. If invasive blood pressure is measured on therved. www.co-anesthesiology.com 5
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FIGURE 2. (Continued).
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Copright arm, at least a palpable pulse on the left arm
should be ensured until deflation of the balloon.
Apparent cardiocirculatory stability during the
occlusion phase should only be considered as a short
gain in time for surgical bleeding control and should
in no way lead to a delay in the further surgical or
interventional management of the bleeding.
Also, the reported mean occlusion times in zone
I and III are 58.5 and 68.0 min, respectively [3
&&
].
Thus, surgical hemostasis should be achieved as
quickly as possible, ideally within 45 min in the6 www.co-anesthesiology.com
yright © 2019 Wolters Kluwer Health, Inc. Unauthcase of zone I occlusion. Otherwise, a lethal out-
come can be expected in most cases [11]. Longer
successful occlusion times (up to 120 min) can be
tolerated for zone III REBOA, for partial occlusion
and for intermittent deflation of the balloon [41].
Damage control surgery should therefore be per-
formed as early as possible. The American College
of Surgeons Committee on Trauma (ACS COT) and
the American College of Emergency Physicians
(ACEP) even recommend that ‘REBOA should not
be placed in emergency departments in institutionsVolume 31  Number 00  Month 2019
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FIGURE 3. REBOA zones. REBOA zone I–III according to Stannard et al. 2011 [36] (modified figure courtesy of Prytime
Medical Boerne, Texas, USA; adapted from Knapp et al. [14]).
Resuscitative endovascular balloon occlusion of the aorta Kulla et al.
C
where the patient cannot receive definitive surgical
care and hemostasis at that same institution’ [19
&
].
In addition, the concept of permissive hypoten-
sion should also be applied to trauma patients with-
out traumatic brain injury (TBI) during the
occlusion phase. In patients with TBI, an excessive
increase in cerebral perfusion pressure (> 70 mmHg)
must be avoided, as this may lead to massive intra-
cranial hemorrhage and worsen neurological out-
come [10,42].Deflation phase
The balloon should be deflated slowly and gradually
in order to avoid reperfusion injuries. The literature
suggests that the mean arterial pressure distal to the
occlusion balloon should be increased by a maxi-
mum of 50% above the initial value every 5 min [43].
A more pragmatic approach would be to slowly
deflate the balloon milliliter by milliliter and to
monitor the hemodynamic response of the patient.
In the event of increasing hemodynamic instability,
the balloon must be reinflated. Therapeutic0952-7907 Copyright  2019 Wolters Kluwer Health, Inc. All rights rese
opyright © 2019 Wolters Kluwer Health, Inc. Unameasures such as volume replacement, the admin-
istration of vasopressors, sodium hydrogencarbon-
ate or glucose/insulin infusion to treat hyperkalemia
should be initiated early and proactively. Especially
during this period, a blood gas analysis should be
conducted every 10 min to monitor the acid-base
balance and the electrolyte balance [44]. As clotting
is expected to deteriorate, the clotting status of the
patient must also be checked regularly, if possible
by thromboelastometry.
The patient must be critically re-evaluated
before the balloon and sheath are removed, as fur-
ther bleeding must be expected after deflation of the
balloon. Large sheaths (12–14 Fr) should be
removed by a vascular surgeon in open surgery.
By contrast, most smaller sheaths do not require
suturing, and 20–30 min of manual compression is
considered to be sufficient [45]. Perfusion distal to
the puncture site should be closely monitored both
clinically and via Doppler sonography. The role of
prophylactic administration of anticoagulants in
this situation is unclear and depends on the
trauma-induced coagulopathy.rved. www.co-anesthesiology.com 7
uthorized reproduction of this article is prohibited.
CE: Alpana; ACO/320214; Total nos of Pages: 14;
ACO 320214
Trauma and transfusion
CopSIDE-EFFECTS AND COMPLICATIONS
In contrast to resuscitative thoracotomy, several
narrative reviews and systematic meta-analyses like
the ones of Ribeiro et al. [46&] and Borger van der
Burg et al. [3
&&
] focus on side-effects and systemic
complications of REBOA. Reviewers state that it is
difficult to distinguish whether a complication is
associated with the procedure or is a result of the
underlying trauma. Furthermore, many patients can
be expected to die before a complication becomes
obvious.Procedural complications
Complications connected to vascular access and the
insertion of the occlusion balloon appear to be rare
(1.5–10%) [3
&&
,4
&
,47
&&
]. Reported femoral access
complications include arterial disruption, dissec-
tion, pseudoaneurysms, hematoma, thromboembo-
lism and extremity ischemia [19
&
]. Teeter et al. [45]
reported no access-related complications at all after
using REBOA 33 times. By contrast, Saito et al. [48]
reported that three patients with vascular injuries or
limb ischemia after REBOA required amputation of a
lower limb. In a meta-analysis of 13 studies (n¼424
trauma patients) with groin access (73.4% percuta-
neous), Manzano-Nunez et al. [47
&&
] found an over-
all complication rate of 5.6%. Lower limb
amputation was required in 2.1%, with at least three
cases directly related to the insertion of REBOA.Table 2. Procedural complications and systemic side-effects of re
Study Patients Procedural comp
Brenner et al. [5] n¼6 (REBOA) None
Brenner et al. [4&] n¼83 (REBOA)
n¼202 (RT)
Extremity ischemia
Distal embolism (n
Infection requiring
Need for patch an
Need for amputati
Retained hemothor
via VATS or thor
DuBose et al. [13] n¼46 (REBOA) Distal embolism (n
Pseudo aneurysm (
Martinelli et al. [38] n¼13 (REBOA) Thrombosis femora
Moore et al. [9] n¼24 (REBOA) None
Ogura et al. [49] n¼7 (REBOA) None
Sadeghi et al. [50&] n¼96 (REBOA) 13 (miscellaneous)
Saito et al. [48] n¼24 (REBOA) Vessel injury (n¼1
Extremity ischemia
Teeter et al. [45] n¼33 (REBOA) None
Tsurukiri et al. [51] n¼16 (REBOA) Failed vascular acc
ARDS, acute respiratory distress syndrome; ARF, acute renal failure; MOF, multiorga
8 www.co-anesthesiology.com
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&&
] analyzed 89 studies
with 1482 REBOA patients and found a
similar complication rate of 3.6%. Table 2
[5,4
&
,9,13,38,45,48,49,50
&
,51] provides an overview
of complications associated with REBOA. It seems
that vascular complications are reduced if smaller
sheets and smaller balloons are used [52], but the
preferable technique for closing the wound is still
under debate [53].Systemic complications
With regard to systemic complications, typical prob-
lems associated with aorta surgery are to be
expected, particularly if aortic occlusion takes place
in zone I: acute renal failure, hepatic failure, meser-
entic ischemia and paraplegia as a result of spinal
ischemia [19
&
,46
&
]. A direct connection may be
assumed between occlusion time and the position
of the aortic occlusion on the one hand, and the
severity of ischemia on the other hand. Up until
now, no pulmonary complications (acute respira-
tory distress syndrome and pulmonary edema) after
REBOA have been reported in the Aortic Occlusion
for Resuscitation in Trauma and Acute Care Surgery
(AORTA) register, but after open aortic occlusion
(0.0 vs. 4.4%, P¼0.149) [13].
The sudden increase in cardiac afterload can
lead to myocardial decompensation and consecu-
tive ischemia in initially hypotensive patients, tosuscitative endovascular balloon occlusion of the aorta
lications Systemic side–effects
None
(n¼1)
¼4)
antibiotics only (n¼1)
gioplasty (n¼2)
on (n¼1)
ax requiring operative evacuation
acotomy (n¼3; 1.5%)
None
None
¼2)
n¼1)
ARF (n¼2)
MOV (n¼2)
Pneumonia (n¼2)
Sepsis (n¼2)
l artery (n¼1) None
None
None
)
(n¼2)
ARF (n¼6)
MOV (n¼9)
ARF (n¼1)
ess (n¼3) ARDS (n¼1)
n failure; RT, resuscitative thoracotomy; VATS, video-assisted thoracoscopy.
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myocardial ischemia and, due to the rise in pulmo-
nary artery pressure, even to pulmonary edema. This
can be somewhat attenuated by slow and initially
incomplete occlusion [15
&
].
We can only roughly estimate what occlusion
times are currently considered to be safe. Animal
experiments have shown that 60 min of occlusion in
zone I is tolerated, whereas 90 min of occlusion led
to organ damage (but the animals survived)
[46
&
,54,55]. In addition, a narrative review of
patients with hemorrhagic shock showed a clear
link between occlusion time and patient survival,
as only two patients with a REBOA time of greater
than 90 min survived [40]. The severity of the
trauma could have been the reason for the long
occlusion time, however. In the clinical setting,
occlusion times between 25 min and a maximum
of 40 min in zone I are currently considered safe
[16,41]. Longer occlusion times in zone III are pre-
sumably tolerable [56].Partial resuscitative endovascular balloon
occlusion of the aorta
Advantages of partial endovascular occlusion of the
aorta (P-REBOA) are that proximal hyperperfusion is
avoided, occlusion time is prolonged and the hemo-
dynamic and metabolic effects of reperfusion are
reduced [12,43,48,57,58
&&
,59]. A current evaluationTable 3. Selected studies on resuscitative endovascular balloon o
Study Patients
Aso et al. [61&] n¼259 severe trauma patients
Thoracic injuries are excluded
Brenner et al. [5] n¼6 patients with abdominal,
pelvic trauma in severe
hemorrhagic shock
Cause of injury: MVA (n¼4),
shootings (n¼6)
n¼1 patient in TCA
Brenner et al. [4&] n¼285 patients (American
Association for the Surgery
of Trauma’s Aortic Occlusion in
Resuscitation for Trauma and
Acute Care Surgery registry)
41.4% penetrating injures
ISS (median) 34
0952-7907 Copyright  2019 Wolters Kluwer Health, Inc. All rights rese
opyright © 2019 Wolters Kluwer Health, Inc. Unaof Japanese register data showed that a median
occlusion time of 58 min for P-REBOA (compared
to 33 min for complete REBOA, P¼0.041) was safe
and tolerated without an increase in the complica-
tion rate [52]. Despite the longer occlusion time,
patients in the P-REBOA group even demonstrated
better hemodynamic stability after deflation than
those who had complete REBOA. The death rates for
both groups after 24 h and 30 days were comparable
[52]. P-REBOA is only possible, however, if patients
can hemodynamically tolerate a partial opening of
the aorta and greater blood loss than with complete
occlusion. Recent findings from Matsumura et al.
[60
&
] revealed that resuscitative thoracotomy and P-
REBOA are not mutually exclusive.PATIENT SELECTION
Table 3 [5,4
&
,9,12,13,38,45,48,49,50
&
,51,60
&
,61
&
,62]
presents indications for the use of REBOA, trauma
mechanisms and treatment outcomes of REBOA
patients. On the basis of figures, the patients most
likely to benefit from REBOA are those with trau-
matic life-threatening hemorrhage below the dia-
phragm who are in hemorrhagic shock and
unresponsive or transiently responsive to the usual
conservative therapeutic measures (e.g. pelvis sling,
infusion, transfusion and vasopressors) [19
&
].
REBOA may also be an option for patients arrivingcclusion of the aorta
Procedure investigated/
methods Results
n¼191 REBOA (22.0% in
cardiopulmonary arrest)
n¼68 RT (61.8% in
cardiopulmonary arrest)
Survival rates: REBOA 52.9
vs. 29.4% for RT, but after
risk adjustment via
propensity score
analysis no difference is
detectable
REBOA treatment n¼4 patients survived (67%)
Patient with TCA: survived
n¼2 patients died due to TBI
RT was used in 71%, and
zone I REBOA in 29%
Overall survival beyond the ED
was 50% (RT 44%, REBOA
63%; P¼0.004) and
survival to discharge was
5% (RT 2.5%, REBOA
9.6%; P¼0.023)
Overall, REBOA can confer a
survival benefit over RT,
particularly in patients not
requiring CPR
rved. www.co-anesthesiology.com 9
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Table 3 (Continued )
Study Patients
Procedure investigated/
methods Results
DuBose et al. [13] n¼114 patients from eight US trauma
centers
Cause of injury: MVA (n¼25), high fall
(n¼2), shooting/stabbing (n¼10),
unclear. (n¼9)
n¼16 TCA at admission
n¼46 REBOA (zone I
n¼33, zone II n¼1,
zone III n¼8)
n¼68 RT
13 of 46 REBOA patients
survived (28%)
Irahara et al. [62] n¼14 patients with abdominal or pelvic
trauma with noncompressible hemorrhage
Blunt trauma (n¼13),
Penetrating trauma (n¼1)
REBOA n¼5 patients survived (36%)
Martinelli et al. [38] n¼13 patients with pelvic trauma in shock
Cause of injury: MVA (n¼5), high fall
(n¼8),
TCA at any time (n¼2)
REBOA n¼6 patients survived (46%)
Patients with TCA survived
n¼6 patients died due to
exsanguination, in one case
not known
Matsumura et al. [60&] n¼106 trauma patients in shock from 18
hospitals requiring REBOA (and RT)
n¼30 REBOA þ RT
n¼76 REBOA only
n¼74 (70%) partial
REBOA
Survival rate 64%
Describes a combined use of
REBOA, partial REBOA and
RT
Moore et al. [9] n¼24 patients with abdominal or pelvic
trauma with noncompressible hemorrhage
(blunt and penetrating)
TCA at admission in seven cases
REBOA n¼9 patients survived (38%)
Survival rate of TCA patients:
0%
Survival rate of non-TCA
patients: 53%
n¼7 patients died due to TBI,
n¼1 patient died in MOV
Cause of death not reported in
eight cases
Norii et al. [12] n¼351 patients from the Japan Trauma
Data Bank (2004–2011)
Abdominal or pelvic trauma with
noncompressible hemorrhage
ISS 35
REBOA treatment
Propensity score analysis
Survival rate 24%
REBOA treatment is associated
with lower survival
compared with similarly ill
trauma patients who did not
receive REBOA (OR: 0.30,
95%-CI: 0.23–0.40)
Ogura et al. [49] n¼7 patients with abdominal or pelvic
trauma in severe hemorrhagic shock
despite transfusion
REBOA treatment 6 of 7 patients survived
n¼1 patient died due to TBI
Sadeghi et al. [50&] Trauma patients in severe hemorrhagic
shock (n¼96 REBOA)
REBOA treatment Survival rate 44% (n¼42)
Saito et al. [48] n¼24 patients with abdominal and/or
pelvic trauma in shock and pending
Cause of injury: MVA (n¼15), high fall
(n¼4), not reported (n¼5)
REBOA treatment Survival rate 58% (n¼15)
Death due to hemorrhagic
shock n¼1, TBI n¼1,
MOV n¼5, unclear n¼3
Teeter et al. [45] n¼33 patients from five Japanese trauma
centers in severe hemorrhagic shock
Cause of injury: blunt trauma (n¼31),
unclear (n¼2)
TCA at admission n¼14
REBOA treatment Survival rate 48% (n¼16)
Patients with TCA 29% (n¼4)
survival rate
Patients without TCA 63%
(n¼12) survival rate
Tsurukiri et al. [51] n¼16 patients in hemorrhagic shock
(SBP<90 mmHg or shock index 1.0)
Cause of injury: MVA (n¼10), high fall
(n¼5), stabbing (n¼1)
REBOA treatment Survival rate 44% (n¼7)
n¼6 patients died due to
exsanguination, n¼1 due to
ARDS, TBI n¼3
ARDS, acute respiratory distress syndrome; CI, confidence interval; MVA, motor vehicle accident; OR, odds ratio; RT, resuscitative thoracotomy; TBI, traumatic
brain injury; TCA, traumatic cardiac arrest.
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FIGURE 4. Clinical decision tree for the in-hospital use of REBOA in adult patients in traumatic hemorrhagic shock. A/P/E,
abdomen/pelvis/extremities; ECG, electrocardiogram; Efast, extended focused assessment with sonography in trauma;
Trauma-CPR, cardiopulmonary resuscitation after traumatic event. [18,63] (modified from Knapp et al. [14]).
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in arrest from injury due to presumed life-threaten-
ing hemorrhage below the diaphragm if resuscita-
tive thoracotomy is not immediately available. A
possible clinical decision tree is depicted in Fig. 4
[14,18,63].
REBOA should not be used in patients with a
major source of bleeding in the chest, mediastinum
or supraclavicular injuries, as this would intensify
the bleeding [64,65]. In patients with concomitant
traumatic brain injuries, clinicians must bear in
mind the problem of proximal hyperperfusion with
consecutive increases in intracranial pressure.
Although this problem may be avoided with P-
REBOA, some experts nevertheless consider severe
TBI as a contraindication for REBOA [59]. Another
contraindication is severe aortic ectasia because of
the lower maximum diameter of newer occlusion
catheters (Table 1). Other contraindications are vas-
cular implants or endoluminal stents at the punc-
ture site or in the occlusion zone.
The advantage of REBOA over a resuscitative
thoracotomy with supradiaphragmatic compression
of the aorta is that the procedure is less invasive.
Although resuscitative thoracotomy involves gen-
eral anesthesia if the patient does not require CPR,
and, as a result, the hemodynamic situation often
deteriorates even further, it is possible to easily
conduct REBOA under local anesthesia or0952-7907 Copyright  2019 Wolters Kluwer Health, Inc. All rights rese
opyright © 2019 Wolters Kluwer Health, Inc. Unaanalgosedation. In addition, REBOA allows a more
selective approach to aorta occlusion than thoracic
clamping in a resuscitative thoracotomy so that, in
theory, fewer systemic side-effects are to be
expected. The prospective AORTA register of the
American Association for the Surgery of Trauma
demonstrated that less time is required for successful
aortic occlusion with REBOA (3.5 min) than with
resuscitative thoracotomy (5.0 min; P¼0.624).
Borger van der Burg et al. [3
&&
] summarized the
data of more than 2960 exsanguating patients. In
patients with trauma, systolic blood pressure
increased by an average of 78.9 mmHg. Despite their
statistical finding that REBOA has a clear survival
benefit in contrast to other treatment options for
patients in severe shock [odds ratio 0.25; 95% con-
fidence interval (CI) (0.11–0.56)], the authors state
in the discussion of their meta-analysis that ‘the
majority of studies lack a sound control group’.
Few data are currently available on the use of
REBOA for patients with traumatic cardiac arrest. A
clinical study comparing REBOA with resuscitative
thoracotomy in such patients was presented at the
American College of Surgeons 2016 Annual Clinical
Congress.This study identifieda trendtowardahigher
mean systolic blood pressure in the REBOA group
compared to the resuscitative thoracotomy group.
There was, however, no significant difference inrved. www.co-anesthesiology.com 11
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Copsurvival between the two groups. Only one of the 36
patients in this study survived until discharge [63]. In
view of current findings, resuscitative thoracotomy
should be carried out on trauma patients requiring
CPR provided that a correct indication has been estab-
lished in accordance with current guidelines [17,66].
In summary, it is currently not possible to favor one
method over the other on the basis of scientific find-
ings, because of different injury patterns, indications
and medical treatment situations [13,67–69].
The results of studies on REBOA treatment out-
comes are shown in Table 3. Moore et al. [9] com-
pared the treatment outcome of patients who, over a
period of 18 months, underwent REBOA (n¼24) or a
resuscitative thoracotomy with direct aortic cross-
clamping (n¼72) in the trauma rooms of two large
US trauma centers. They found a significantly
higher survival rate for REBOA patients than for
patients with open aortic clamping (38 vs. 10%,
P¼0.003). However, 71% of the REBOA patients
still had vital signs upon admission. This was the
case in only 38% of the resuscitative thoracotomy
patients. On the basis of case series and observa-
tional studies in the literature, it is not possible to
say whether the treatment outcome of the patients
is improved by REBOA and whether resuscitative
thoracotomy or REBOA is the preferred procedure.
In this context, the results of several Japanese
studies have to be discussed. One study used the
propensity score method to compare the treatment
outcome of 625 patients whounderwent REBOA with
the treatment outcome of 625 similarly injured
patients who did not undergo REBOA [11]. The
REBOA patient group had a significantly higher hos-
pital mortality rate [62 vs. 45% (95% CI: 11–22%)].
The authors attributed this finding to the fact that it
took a median time of 97 min (95% CI: 90–104 min)
to perform surgery after the patient was admitted to
the traumaroom,and thatenormous ischemia/reper-
fusion damage could be the reason for the negative
treatment outcomes. Nevertheless, these results
clearly show that, after REBOA, an intervention for
definitive bleeding control (e.g. surgery and emboli-
zation) must be conducted without delay. In addi-
tion, in particular in zone I, REBOA cannot currently
be recommended for patients who must be trans-
ported to a suitably equipped trauma center for fur-
ther treatment. In 2017, Aso et al. [61
&
] published
another retrospective Japanese register study which
found no survival benefit between REBOA and resus-
citative thoracotomy in the case of trauma.CONCLUSION
In the future, REBOA could assume an important role
as an endovascular and catheter-based procedure for12 www.co-anesthesiology.com
yright © 2019 Wolters Kluwer Health, Inc. Unauthcontrolling bleeding in the clinical primary care of
patients with hemorrhagic shock. Together with
other endovascular procedures such as embolization
and interprofessional care concepts (e.g. trauma
hybrid operating room and resuscitation with angi-
ography, percutaneous techniques and operative
repair) [32,70–73], REBOA could become an addi-
tional important pillar for treatment of hemorrhage
in severely injured patients, especially if resuscitative
thoracotomy is not immediately available.
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